A Phase 1 Placebo-Controlled Trial to Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Escalating Oral Doses of PF-04991532 in Adult Patients With Type 2 Diabetes Mellitus (T2DM).
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2011
At a glance
- Drugs PF 4991532 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 08 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Mar 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.